Bill > SF2176

This bill introduces new requirements for health carriers and pharmacy benefit managers regarding prescription drug rebates and cost-sharing for enrollees in Minnesota. The bill defines several key terms, including "rebate," which encompasses various price concessions and negotiated discounts that accrue to health carriers from drug manufacturers or pharmacies. It mandates that at the point of sale, an enrollee's out-of-pocket costs (defined as "defined cost-sharing") must be calculated using a price reduced by 100 percent of all rebates associated with the prescription drug. The bill also includes strict confidentiality provisions that prohibit health carriers from revealing specific rebate information, protecting such details as trade secrets. Additionally, the legislation establishes enforcement mechanisms, allowing for potential sanctions, civil penalties, or license suspension for health carriers or pharmacy benefit managers who fail to comply with these new regulations. The overall aim appears to be ensuring that enrollees directly benefit from drug price rebates by reducing their upfront prescription costs, rather than having these savings retained by health insurance companies.

Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF2176&ssn=0&y=2025